ARTICLE | Financial News
InflaRx prices $100M IPO
November 8, 2017 7:12 PM UTC
InflaRx N.V. (NASDAQ:IFRX) raised $100 million on Wednesday through the sale of 6.7 million shares at $15 in an IPO underwritten by JPMorgan, Leerink and BMO Capital Markets. The share price is at the midpoint of InflaRx's proposed $14-$16 range and values the company at $351.2 million.
In October, InflaRx raised $55 million in a series D round (see BioCentury Extra, Oct. 13)...
BCIQ Company Profiles
BCIQ Target Profiles